A detailed history of Royce & Associates LP transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 237,416 shares of SLP stock, worth $6.55 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
237,416
Previous 184,324 28.8%
Holding current value
$6.55 Million
Previous $8.96 Million 15.2%
% of portfolio
0.07%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$30.46 - $46.86 $1.62 Million - $2.49 Million
53,092 Added 28.8%
237,416 $7.6 Million
Q2 2024

Aug 13, 2024

SELL
$38.46 - $50.95 $890,848 - $1.18 Million
-23,163 Reduced 11.16%
184,324 $8.96 Million
Q1 2024

May 13, 2024

SELL
$37.48 - $44.74 $3.11 Million - $3.71 Million
-82,859 Reduced 28.54%
207,487 $8.54 Million
Q4 2023

Feb 12, 2024

BUY
$33.36 - $45.71 $1.4 Million - $1.92 Million
42,025 Added 16.92%
290,346 $13 Million
Q3 2023

Nov 09, 2023

SELL
$40.03 - $51.51 $571,027 - $734,790
-14,265 Reduced 5.43%
248,321 $10.4 Million
Q2 2023

Aug 07, 2023

SELL
$40.45 - $48.0 $4.29 Million - $5.09 Million
-105,940 Reduced 28.75%
262,586 $11.4 Million
Q1 2023

May 04, 2023

BUY
$34.96 - $43.94 $321,632 - $404,248
9,200 Added 2.56%
368,526 $16.2 Million
Q4 2022

May 23, 2023

SELL
$36.55 - $51.15 $336,260 - $470,580
-9,200 Reduced 2.5%
359,326 $13.1 Million
Q4 2022

Feb 13, 2023

BUY
$36.55 - $51.15 $2.4 Million - $3.36 Million
65,620 Added 22.34%
359,326 $13.1 Million
Q3 2022

Nov 03, 2022

SELL
$47.75 - $66.88 $4.2 Million - $5.88 Million
-87,980 Reduced 23.05%
293,706 $14.3 Million
Q2 2022

Aug 04, 2022

SELL
$40.55 - $51.76 $2.7 Million - $3.45 Million
-66,647 Reduced 14.87%
381,686 $18.8 Million
Q1 2022

May 05, 2022

BUY
$36.56 - $50.98 $274,200 - $382,350
7,500 Added 1.7%
448,333 $22.9 Million
Q4 2021

Feb 07, 2022

SELL
$37.1 - $57.45 $2.25 Million - $3.48 Million
-60,636 Reduced 12.09%
440,833 $20.9 Million
Q3 2021

Nov 10, 2021

BUY
$38.45 - $55.66 $1.7 Million - $2.47 Million
44,300 Added 9.69%
501,469 $19.8 Million
Q2 2021

Aug 06, 2021

BUY
$49.67 - $68.96 $2.39 Million - $3.32 Million
48,101 Added 11.76%
457,169 $25.1 Million
Q1 2021

May 10, 2021

BUY
$60.06 - $89.52 $5.24 Million - $7.81 Million
87,208 Added 27.1%
409,068 $25.9 Million
Q4 2020

Feb 08, 2021

BUY
$53.26 - $77.18 $1.95 Million - $2.83 Million
36,690 Added 12.87%
321,860 $23.1 Million
Q3 2020

Nov 12, 2020

SELL
$57.51 - $75.36 $1.1 Million - $1.44 Million
-19,050 Reduced 6.26%
285,170 $21.5 Million
Q2 2020

Aug 07, 2020

SELL
$32.91 - $59.82 $5.68 Million - $10.3 Million
-172,500 Reduced 36.18%
304,220 $18.2 Million
Q1 2020

May 12, 2020

BUY
$26.79 - $38.99 $1.28 Million - $1.86 Million
47,650 Added 11.11%
476,720 $16.6 Million
Q4 2019

Feb 06, 2020

BUY
$29.07 - $35.63 $3.5 Million - $4.29 Million
120,514 Added 39.06%
429,070 $12.5 Million
Q3 2019

Nov 13, 2019

BUY
$28.19 - $41.75 $792,139 - $1.17 Million
28,100 Added 10.02%
308,556 $10.7 Million
Q2 2019

Aug 12, 2019

BUY
$19.91 - $28.97 $2.49 Million - $3.62 Million
125,048 Added 80.46%
280,456 $8.01 Million
Q1 2019

May 09, 2019

BUY
$18.84 - $21.36 $1.97 Million - $2.24 Million
104,696 Added 206.45%
155,408 $3.28 Million
Q4 2018

Feb 11, 2019

BUY
$17.56 - $21.2 $876,630 - $1.06 Million
49,922 Added 6319.24%
50,712 $1.01 Million
Q3 2018

Nov 13, 2018

BUY
$17.1 - $23.55 $5,266 - $7,253
308 Added 63.9%
790 $16,000
Q2 2018

Aug 09, 2018

BUY
$14.65 - $23.75 $1,831 - $2,968
125 Added 35.01%
482 $11,000
Q1 2018

May 14, 2018

SELL
$14.4 - $16.8 $288 - $336
-20 Reduced 5.31%
357 $5,000
Q4 2017

Feb 09, 2018

BUY
$15.3 - $17.4 $229 - $261
15 Added 4.14%
377 $6,000
Q3 2017

Nov 13, 2017

BUY
$13.7 - $15.65 $4,959 - $5,665
362
362 $6,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $560M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.